← Eichor
Study identifier: NCT07325708 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control

Condition: Upper Limb Amputation Below Elbow (Injury) · Wrist Disarticulation · Transradial Amputation  ·  Sponsor: Phantom Neuro Inc.

PhaseNA
Planned participants10
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The CYBORG Study is a first-in-human clinical investigation evaluating the safety and performance of the Phantom X System, an implantable electromyography (EMG) sensor array designed to provide control of upper-limb prostheses. The study will assess surgical feasibility, device function, signal quality, and the system's ability to support intuitive prosthetic control during functional tasks. Participants will undergo implantation of the Phantom X sensors and complete a series of in-clinic visits to assess functional performance of the Phantom X system. Patient-reported outcomes will also be collected at various timepoints.

This description comes directly from the study's public registry record.

Talk to the study team

Vinod Sharma, PhD  ·  +1 512-763-0152  ·  vinod@phantomneuro.com

Always discuss trial participation with your own doctor first.

Locations (2)

Cabrini Health LtdMalvern, Victoria, AustraliaRecruiting
ProMotion Prosthetics Pty LtdMoorabbin, Victoria, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07325708